Literature DB >> 2060392

Peak expiratory flow rates in possible occupational asthma.

G M Liss1, S M Tarlo.   

Abstract

Objective criteria for interpretation of peak expiratory flow rate readings were assessed in 50 patients evaluated for suspected occupational asthma who had at least two weeks of PEFR readings and an objective diagnosis based on other investigations. The prevalence of OA was 36 percent. Peak flows were interpreted by two observers blinded to other results. Criteria for a PEFR interpretation of OA were as follow: diurnal variation greater than or equal to 20 percent relatively more frequently or with greater variation on working days than days off work. With the objective diagnoses as the gold standard, the sensitivity of the PEFR interpretations was 72 percent for OA; specificity for no asthma was 53 percent. Excluding those with greater than or equal to 20 percent variation on only one day sensitivity improved to 93 percent for OA, and specificity to 77 percent. There was an acceptable level of interobserver variation (kappa 62 to 83 percent). We conclude that simple objective criteria for PEFR interpretation can be developed with acceptable interobserver variation.

Entities:  

Mesh:

Year:  1991        PMID: 2060392     DOI: 10.1378/chest.100.1.63

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  10 in total

1.  Development of an expert system for the interpretation of serial peak expiratory flow measurements in the diagnosis of occupational asthma. Midlands Thoracic Society Research Group.

Authors:  P S Burge; C F Pantin; D T Newton; P F Gannon; P Bright; J Belcher; J McCoach; D R Baldwin; C B Burge
Journal:  Occup Environ Med       Date:  1999-11       Impact factor: 4.402

Review 2.  Diagnosis of occupational asthma: an update.

Authors:  Edgardo J Jares; Carlos E Baena-Cagnani; R Maximiliano Gómez
Journal:  Curr Allergy Asthma Rep       Date:  2012-06       Impact factor: 4.806

3.  Factors associated with severity of occupational asthma with a latency period at diagnosis.

Authors:  A Descatha; H Leproust; D Choudat; R Garnier; J-C Pairon; J Ameille
Journal:  Allergy       Date:  2007-07       Impact factor: 13.146

Review 4.  Occupational lung disease. 8. The diagnosis of occupational asthma from serial measurements of lung function at and away from work.

Authors:  P Bright; P S Burge
Journal:  Thorax       Date:  1996-08       Impact factor: 9.139

5.  Development of OASYS-2: a system for the analysis of serial measurement of peak expiratory flow in workers with suspected occupational asthma.

Authors:  P F Gannon; D T Newton; J Belcher; C F Pantin; P S Burge
Journal:  Thorax       Date:  1996-05       Impact factor: 9.139

Review 6.  Evidence based guidelines for the prevention, identification, and management of occupational asthma.

Authors:  P J Nicholson; P Cullinan; A J Newman Taylor; P S Burge; C Boyle
Journal:  Occup Environ Med       Date:  2005-05       Impact factor: 4.402

7.  The validation of work-related self-reported asthma exacerbation.

Authors:  Aimee R Bolen; Paul K Henneberger; Xiaoming Liang; Susan R Sama; Peggy A Preusse; Richard A Rosiello; Donald K Milton
Journal:  Occup Environ Med       Date:  2006-12-20       Impact factor: 4.402

8.  Are serum eosinophilic cationic protein levels of toll collectors affected by diesel exhaust exposure?

Authors:  Cahit Bilgin; Peri Arbak; Ozlem Yavuz; Ege Gulec Balbay; Oner Balbay; Ali Nihat Annakkaya
Journal:  Pak J Med Sci       Date:  2016 Sep-Oct       Impact factor: 1.088

9.  Prevalence and Risk Factors of Work-Related Asthma in Hospital Cleaning Workers.

Authors:  Seval Müzeyyen Ecin; Abdulsamet Sandal; Sultan Pınar Çetintepe; Adem Koyuncu; Özlem Kar Kurt; Ali Naci Yıldız; Ahmet Uğur Demir
Journal:  Turk Thorac J       Date:  2022-05

10.  Diagnostic approach in cases with suspected work-related asthma.

Authors:  Tor B Aasen; P Sherwood Burge; Paul K Henneberger; Vivi Schlünssen; Xaver Baur
Journal:  J Occup Med Toxicol       Date:  2013-06-14       Impact factor: 2.646

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.